Increased expressions of programmed cell death protein 1 (PD-1) on T cells and programmed death ligand 1 (PD-L1) on blasts have been demonstrated in patients diagnosed with AML and MDS, particularly in those with R/R disease, correlating with an unfavorable prognosis [59]. The gene discussed is PDCD1; the disease is myelodysplastic syndrome.